KR20170136123A - Self-healing polyethers and process for the preparation thereof - Google Patents

Self-healing polyethers and process for the preparation thereof Download PDF

Info

Publication number
KR20170136123A
KR20170136123A KR1020160067532A KR20160067532A KR20170136123A KR 20170136123 A KR20170136123 A KR 20170136123A KR 1020160067532 A KR1020160067532 A KR 1020160067532A KR 20160067532 A KR20160067532 A KR 20160067532A KR 20170136123 A KR20170136123 A KR 20170136123A
Authority
KR
South Korea
Prior art keywords
self
healing
polyether compound
oco
formula
Prior art date
Application number
KR1020160067532A
Other languages
Korean (ko)
Other versions
KR101836967B1 (en
Inventor
이문호
권경호
이진석
송성진
한관영
임성규
박병민
장동훈
김현중
김홍철
김정래
Original Assignee
주식회사 쎄코
포항공과대학교 산학협력단
단국대학교 천안캠퍼스 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 쎄코, 포항공과대학교 산학협력단, 단국대학교 천안캠퍼스 산학협력단 filed Critical 주식회사 쎄코
Priority to KR1020160067532A priority Critical patent/KR101836967B1/en
Priority to PCT/KR2017/005634 priority patent/WO2017209486A1/en
Publication of KR20170136123A publication Critical patent/KR20170136123A/en
Application granted granted Critical
Publication of KR101836967B1 publication Critical patent/KR101836967B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2636Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing sulfur
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/321Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/323Polymers modified by chemical after-treatment with inorganic compounds containing halogens
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33303Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
    • C08G65/33317Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group heterocyclic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a self-healing functional polyether compound with a weight average molecular weight of 5,000 to 5,000,000, preferably 5,000 to 500,000, represented by chemical formula 1, a preparation method of the polyether compound, and a polymer thin film produced from the polyether compound. The self-healing functional polyether compound used in the present invention facilitates the production of the polymer thin film using the self-healing functional polyether compound as an economical material which is easily processed and can be easily coated on various substrates. Further, the polymer thin film can recover fine damages on the surface thereof by self-healing characteristics of polyether. Particularly, the polymer thin film can maximize recovery ability and enables a repeated effective recovery by using self-healing functional molecules.

Description

자가치유 폴리에테르 화합물 및 이의 제조방법{SELF-HEALING POLYETHERS AND PROCESS FOR THE PREPARATION THEREOF}[0001] SELF-HEALING POLYETHER COMPOUND AND PROCESS FOR PREPARING THE SAME [0002]

본 발명은 고분자 도막의 스크래치 등을 자가 치유하는 신규한 폴리에테르 화합물 및 이의 제조방법과 이로부터 제조된 고분자 도막에 관한 것이다.The present invention relates to a novel polyether compound which self-heals scratches and the like of a polymer coating film, a method for producing the same, and a polymer coating film prepared therefrom.

종래에 알려진 고분자 도막의 형성된 스크래치 등의 자가 치유에 대한 방법은 크게 두 가지 방법으로 구분이 가능하다.Conventionally known methods for self-healing such as scratching of a polymer coating can be classified into two methods.

하나는 물질 내에 치유제(Healing Agents)를 캡슐형태(Capsular System)나 관다발형태(Vascular System)로 도입하여, 외력에 의해 미세손상이 일어나게 되면 치유제가 누출되어 손상부위를 채워줌으로써 복원하는 방법이며(공개특허 제10-2004-005997, 10-2015-0049852, 등록특허 제10-1168038, 10-1498361호), 다른 하나는 외부 치유제의 도움없이 물질 자체가 가지는 탄성(Elasticity), 고분자 사슬 이동성(Chain Mobility), 광반응성 기능기, 열반응성 기능기, 비공유결합 기능기 등에 의해서 미세손상을 복원하는 방법이 있다(공개특허 제10-2012-0076149, 10-2015-0097902, 10-2016-0028556호).One method is to introduce healing agents into capsular system or vascular system and to recover by microinflammation when the healing agent leaks and fills the damaged area. And the other is the elasticity of the material itself, the polymer chain mobility (not shown) without the aid of the external healing agent Chain Mobility), a photoreactive functional group, a thermoreactive functional group, and a noncovalent functional functional group (Japanese Patent Laid-Open Nos. 10-2012-0076149, 10-2015-0097902, 10-2016-0028556 ).

첫 번째로 언급한 캡슐 및 관다발에 도입된 치유제를 이용한 회복 방법은 넓은 범위의 손상을 회복할 수 있지만, 반복적인 회복과 치유제의 보전성에 한계가 있다.The recovery methods using the healing agents introduced in the first mentioned capsules and vents can restore a wide range of damage, but have limited repetitive recovery and the integrity of the healing agent.

이러한 단점을 극복하기 위해 자가치유 물질의 반복적인 회복 능력을 부여하기 위하여 물질 자체가 가지고 있는 탄성(Elasticity), 고분자 사슬 이동성(Chain Mobility), 광/열-반응성 기능기, 초분자를 도입하여 물질 자체가 가지는 회복 능력을 향상시키고자 하는 연구가 많이 이루어지고 있는 실정이다.In order to overcome these disadvantages, it is necessary to introduce elasticity, chain mobility, light / heat-reactive functional groups, and supramolecules possessed by the material itself in order to impart the repetitive recovery ability of the self- Researches have been carried out to improve the recovery ability of the patients.

특히, 현대사회에 필수요소인 전자기기 및 디스플레이 기기의 표면보호물질로 응용하기 위해서는 반복적 회복 능력의 필요성이 대두되고 있으며, 회복 후에 물질이 가진 고유의 물성을 그대로 복원할 수 있는 능력을 필요로 한다.In particular, in order to be applied as a surface protecting material for electronic devices and display devices, which are indispensable elements in modern society, it is necessary to have a repetitive recovery ability and it is necessary to restore the inherent physical properties of the material after recovery .

이에 브러쉬 고분자를 이용한 자가치유 브러쉬 고분자는 앞서 언급한 필요조건을 충족시킬 수 있는 유력한 물질이다.Accordingly, the self-healing brush polymer using the brush polymer is a potent substance that can meet the aforementioned requirements.

KRKR 102004005997102004005997 AA KRKR 10201500498521020150049852 AA KRKR 101168038101168038 B1B1 KRKR 101498361101498361 B1B1 KRKR 10201200761491020120076149 AA KRKR 10201500979021020150097902 AA KRKR 10201600285561020160028556 AA

본 발명은 폴리에테르 수지의 브러쉬에 다양한 기능성 분자를 도입하여, 자가치유 능력을 극대화한 폴리에테르 화합물 및 이의 제조방법과 이로부터 제조된 고분자 도막을 제공하고자 하는 것을 목적으로 한다. It is an object of the present invention to provide a polyether compound that maximizes self-healing ability by introducing various functional molecules into a brush of a polyether resin, a process for producing the same, and a polymer coating film prepared therefrom.

상기의 문제점을 해결하고자 본 발명은 자가치유 기능성 분자를 브러쉬 말단으로 가지는 하기 화학식 1의 폴리에테르 화합물과 이의 제조 방법 및 이를 이용한 박막을 제공하고자 한다.In order to solve the above problems, the present invention provides a polyether compound having a self-healing functional molecule at the brush end, a process for producing the same, and a thin film using the same.

[화학식 1][Chemical Formula 1]

Figure pat00001
Figure pat00001

브러쉬 고분자 물질은 고분자 주쇄와 도입된 브러쉬의 화학구조에 따라서 다양한 화학적, 물리적 특성을 나타낼 수 있으며, 특히, 고분자의 탄성(Elasticity), 얽힘(Entanglement), 사슬 이동성(Chain Mobility) 등에 영향을 준다. Brush polymer materials can exhibit various chemical and physical properties depending on the chemical structure of the polymer main chain and the introduced brush, and particularly affect the elasticity, entanglement, and chain mobility of the polymer.

이러한 물성은 고분자의 자가치유 응용분야에 활용이 가능하며, 브러쉬에 다양한 기능성 분자를 도입함으로써 자가치유 능력을 극대화할 수 있다.This property can be applied to the self-healing application of polymers, and it is possible to maximize the self-healing ability by introducing various functional molecules into the brush.

본 발명에 이용되는 자가치유 브러쉬 고분자 물질은 물질 자체가 가지는 탄성체 특성과 사슬의 유연성과 같은 고유물성뿐만 아니라, 브러쉬에 도입된 자가치유 기능성 분자를 이용하여 반복적인 회복 능력을 부여하는 동시에, 공유 결합과 비공유 결합의 복합적인 보완을 통해 회복 능력을 극대화시킬 수 있으며, 이러한 효과적인 자가치유 능력을 이용하여 표면보호물질로 응용이 가능할 것으로 기대된다. The self-healing brush polymer material used in the present invention not only has inherent physical properties such as elastic properties and chain flexibility possessed by the material itself, but also imparts repetitive recovery ability by using the self-healing functional molecules introduced into the brush, And non-covalent bonding, it is expected that it will be possible to apply it as a surface protecting material by utilizing this effective self-healing ability.

본 발명의 폴리에테르 화합물에 의하여 이루어진 고분자의 박막은 고분자 주쇄에 곁가지로 도입인 자가치유 기능성 분자에 의해서 자가치유 기능성 물질로의 응용이 가능하다.The thin film of the polymer formed by the polyether compound of the present invention can be applied as a self-healing functional material by a self-healing functional molecule, which is introduced side chain into the polymer main chain.

본 발명의 폴리에테르 화합물은 고분자 주쇄에 도입된 브러쉬에 다양한 기능성 분자를 도입함으로써, 자가치유 능력을 극대화할 수 있는 효과가 있다.The polyether compound of the present invention has an effect of maximizing the self-healing ability by introducing various functional molecules into the brush introduced into the polymer main chain.

또한 본 발명에 이용되는 폴리에테르 화합물은 물질 자체가 가지는 탄성체 특성과 사슬의 유연성과 같은 고유물성뿐만 아니라, 브러쉬에 도입된 자가치유 기능성 분자를 이용하여 반복적인 회복 능력을 부여하는 동시에, 공유 결합과 비공유 결합의 복합적인 보완을 통해 회복 능력을 극대화시킬 수 있는 효과도 있는 것이며, 이러한 효과적인 자가치유 능력을 이용하여 표면보호물질로 다양한 응용이 가능할 것으로 기대된다. In addition, the polyether compound used in the present invention not only has inherent physical properties such as elastic properties and chain flexibility possessed by the material itself, but also imparts repetitive recovery ability by using self-healing functional molecules introduced into the brush, It is possible to maximize the recovery ability through the complementary combination of non-covalent bonding. It is expected that various applications as surface protecting materials are expected to be possible by utilizing such effective self-healing ability.

도 1은 본 발명의 실시예에 의한 고분자 박막의 자가치유 특성을 설명하는 개략도이다.
도 2는 본 발명의 자가치유 고분자 박막의 광학현미경 카메라 이미지로 자가치유 전후 차이를 나타내는 이미지이다.
도 3은 본 발명의 자가치유 고분자 박막의 표면단차측정기를 통해 얻은 고분자 박막의 표면의 두께 변화를 나타내는 그래프이다.
1 is a schematic view for explaining self-healing characteristics of a polymer thin film according to an embodiment of the present invention.
FIG. 2 is an image showing an optical microscope camera image of the self-healing polymer thin film of the present invention before and after self-healing.
FIG. 3 is a graph showing a change in thickness of a surface of a polymer thin film obtained through a surface step difference meter of the self-healing polymer thin film of the present invention.

본 발명에서는, 하기 화학식 1의 자가치유 기능 폴리에테르 화합물을 제공한다.In the present invention, a self-healing functional polyether compound represented by the following formula (1) is provided.

[화학식 1][Chemical Formula 1]

Figure pat00002
Figure pat00002

상기 식에서, L은 탄소 수 1 내지 20개의 지방족 유도체 또는 방향족 유도체이고; Wherein L is an aliphatic or aromatic derivative having from 1 to 20 carbon atoms;

R1 및 R2는 서로에 관계없이 수소, 탄소 수 1 내지 20개의 지방족 유도체이고, ρ는 0 내지 20 정수의 반복단위이며;R 1 and R 2 are each independently hydrogen or an aliphatic derivative having 1 to 20 carbon atoms, and p is a repeating unit of 0 to 20 integers;

m 및 n은 폴리에테르 단위체의 함량(mol%)을 나타낸 것으로, 0<m=100이고 0=n<100이며, m + n = 100이고; m and n represent the content (mol%) of the polyether unit, 0 <m = 100 and 0 = n <100, and m + n = 100;

Y는 H, -CH2X(X= F, Cl, Br 또는 I), 탄소 수 1 내지 20개의 지방족 유도체 또는 –Z 말단에 U를 포함하는 고리 및 지방족 유도체이고; Y is H, -CH 2 X (X = F, Cl, Br or I), a ring carbon and an aliphatic derivative comprising a U in 1 to 20 aliphatic derivatives or -Z-terminal;

Z는 -CH2SRO-, -CH2SROCO-, -CH2SRCOO-, -CH2SRO-, -CH2SRNHCO-, -CH2SROCO(CH2)2OCO-, -CH2SRCO-, -CH2SO2RO-, -CH2SO2ROCO-, -CH2SO2RCOO-, -CH2SO2RNHCO-, -CH2SO2ROCO(CH2)2OCO-, -CH2SO2RCO-, -OCORO-, -OCOROCO-, -OCORCOO-, -OCORNHCO-, -OCOROCO(CH2)2OCO-, -OCORCO-, -COORO-, -COOROCO-, -COORCOO-, -COORNHCO-, -COOROCO(CH2)2OCO-, -COORCO-, -ORO-, -OROCO-, -ORCOO-, -ORNHCO-, -OROCO(CH2)2OCO-, -ORCO-, -NHRO-, -NHROCO-, -NHRCOO-, -NHRNHCO-, -NHROCO(CH2)2OCO-, -NHRCO-, -CH2RO-, -CH2ROCO-, -CH2RCOO-, -CH2RNHCO-, -CH2ROCO(CH2)2OCO-, -OC6H4RO-, -OC6H4ROCO-, -OC6H4RCOO-, -OC6H4RNHCO-, -OC6H4ROCO(CH2)2OCO-, -OC6H4RCO-, -OC6H4COOROCO-, -OC6H4COORCOO-, -OC6H4COORO-, -OC6H4COORNHCO-, -OC6H4COOROCO(CH2)2OCO-, -OC6H4COORCO- 또는 -OC6H4CONHROCO-, -OC6H4CONHRCOO-, -OC6H4CONHRO-, -OC6H4CONHRNHCO-, -OC6H4CONHROCO(CH2)2OCO-, -OC6H4CONHRCO-로 이루어진 군으로부터 선택되는 지방족 유도체 또는 방향족 유도체이며;Z is -CH 2 SRO-, -CH 2 SROCO-, -CH 2 SRCO-, -CH 2 SRO-, -CH 2 SRNHCO-, -CH 2 SROCO (CH 2 ) 2 OCO-, -CH 2 SRCO-, -CH 2 SO 2 RO-, -CH 2 SO 2 ROCO-, -CH 2 SO 2 RCOO-, -CH 2 SO 2 RNHCO-, -CH 2 SO 2 ROCO (CH 2 ) 2 OCO-, -CH 2 SO 2 RCO-, -OCORO-, -OCOROCO-, -OCORCOO- , -OCORNHCO-, -OCOROCO (CH 2) 2 OCO-, -OCORCO-, -COORO-, -COOROCO-, -COORCOO-, -COORNHCO-, -COOROCO (CH 2 ) 2 OCO-, -COORCO-, -ORO-, -OROCO-, -ORCOO-, -ORNHCO-, -OROCO (CH 2 ) 2 OCO-, -ORCO-, -NHRO-, -NHROCO -, -NHRCOO-, -NHRNHCO-, -NHCO (CH 2 ) 2 OCO-, -NHRCO-, -CH 2 RO-, -CH 2 ROCO-, -CH 2 RCOO-, -CH 2 RNHCO-, -CH 2 ROCO (CH 2 ) 2 OCO-, -OC 6 H 4 RO-, -OC 6 H 4 ROCO-, -OC 6 H 4 RCOO-, -OC 6 H 4 RNHCO-, -OC 6 H 4 ROCO 2) 2 OCO-, -OC 6 H 4 RCO-, -OC 6 H 4 COOROCO-, -OC 6 H 4 COORCOO-, -OC 6 H 4 COORO-, -OC 6 H 4 COORNHCO-, -OC 6 H 4 COOROCO (CH 2 ) 2 OCO-, -OC 6 H 4 COORCO- or -OC 6 H 4 CONHROCO-, -OC 6 H 4 CONHRCOO-, -OC 6 H 4 CONHRO-, -OC 6 H 4 CONHRNHCO-, -OC 6 H 4 CONHROCO (CH 2 ) 2 OCO-, -OC 6 H 4 CONHRCO- Lt; / RTI &gt; is an aliphatic or aromatic derivative selected from the group consisting of:

U는 수산화기 또는 하기에 표기한 화학유도체로 이루어진 군에서 2 내지 10개의 화학유도체로 선택되고, 바람직하게는 2 내지 5개의 화학유도체로 선택된다. 여기에서 R은 수소, 탄소 수 1 내지 20개의 지방족 유도체 또는 방향족 유도체이다.U is selected from 2 to 10 chemical derivatives, preferably 2 to 5 chemical derivatives, in the group consisting of hydroxyl groups or chemical derivatives indicated below. Wherein R is hydrogen, an aliphatic or aromatic derivative of 1 to 20 carbon atoms.

Figure pat00003
Figure pat00003

Figure pat00004
Figure pat00004

상기 자가치유 기능 폴리에테르 화합물의 중량평균 분자량은 5,000 내지 5,000,000, 바람직하게는 5,000 내지 500,000이다. The weight-average molecular weight of the self-healing functional polyether compound is 5,000 to 5,000,000, preferably 5,000 to 500,000.

본 발명에 사용된 자가치유 기능 폴리에테르 화합물은 가공이 용이하고, 다양한 기질에 쉽게 코팅될 수 있는 경제적인 물질로써, 자가치유 기능 폴리에테르를 이용한 고분자 박막을 제조하는데 용이하다.The self-healing polyether compound used in the present invention is an economical material that is easy to process and easily coated on various substrates, and is easy to produce a polymer thin film using self-healing polyether.

또한, 이 고분자 박막은 고분자의 자가치유 특성에 의하여 표면의 미세 손상을 회복할 수 있으며, 특히 자가치유 기능성 분자를 이용하여 회복 능력을 극대화하고 반복적으로 효과적인 회복이 가능하다.In addition, the polymer thin film can recover the micro-damage on the surface due to the self-healing property of the polymer, and it is possible to maximize the recovery ability by using the self-healing functional molecule, and to recover effectively repeatedly.

본 발명에 따른 화학식 1의 고분자로서, 대표적인 예로 화학식 2의 구조를 갖는 폴리[옥시((N-아세틸글라이시닐옥시)헥실티오메틸)에틸렌-랜-옥시((시나모일옥시)헥실티오메틸)에틸렌-랜-옥시((4-네오펜티옥시설포닐벤조익)헥실티오메틸)에틸렌-랜- 옥시((6-(3,5-디메틸-1H-피라졸-1-카르복사미도헥실카바메이트))헥실티오메틸)에틸렌-랜-옥시(6-하이드록시헥실티오메틸)에틸렌-랜-옥시(클로로메틸)에틸렌]이 있다.Representative examples of the polymer of Formula 1 according to the present invention include poly [oxy ((N-acetylglycinyloxy) hexylthiomethyl) ethylene-l-oxy ((cinnamoyloxy) hexylthiomethyl) ((6- (3,5-dimethyl-1H-pyrazole-1-carboxyimidohexylcarbamate (ethyl) )) Hexylthiomethyl) ethylene-l-oxy (6-hydroxyhexylthiomethyl) ethylene-l-oxy (chloromethyl) ethylene].

하기 화합물 2에서, 상기 화학식 1에서 표기한 U의 화학유도체로 이루어진 군에서 선택된 4개의 자가치유 기능성 분자를 대표적인 예로써 표시하되, 본 발명에서 소개하는 자가치유 기능 폴리에테르 화합물은 하기 화학식 2로 표기한 고분자 화합물에만 한정되는 것은 아니며 위에서 기재된 유도체 화합물들과 용이하게 치환이 가능하다.In the following compound 2, four self-healing functional molecules selected from the group consisting of the chemical derivatives of U shown in the above formula (1) are represented as representative examples. The self-healing functional polyether compounds shown in the present invention are represented by the following formula It is not limited to a single polymer compound but can be easily substituted with the above-described derivative compounds.

[화학식 2](2)

Figure pat00005
Figure pat00005

상기 화학식 2의 자가치유 기능성 분자를 브러쉬 말단으로 가지는 폴리에테르 화합물에서 폴리에테르 단위체의 함량(mol%)을 나타내는 l, o, p, q, r, n은 0<l≤100, 0<o≤100, 0<p≤100, 0<q≤100, 0≤r<100, 0≤n<100이며, l + o + p + q + r + n = 100이고; 바람직하게는 0<l≤50, 0<o≤50, 0<p=50, 0<q≤50, 0≤r<50, 0≤n<50 이다.P, q, r, and n representing the content (mol%) of the polyether unit in the polyether compound having the self-healing functional molecule of Formula 2 as a brush terminal satisfy 0 < 100, 0 <p? 100, 0? Q? 100, 0? R <100, 0? N <100, l + o + p + q + r + n = 100; Preferably, 0 <l? 50, 0 <o? 50, 0 <p = 50, 0 <q? 50, 0? R <50, 0? N <50.

본 발명에 따른 화학식 1의 폴리에테르 화합물은 먼저 하기 화학식 3의 단량체를 양이온 개환 중합 반응을 이용하여 하기 화학식 4의 폴리에테르 화합물을 합성한다. The polyether compound of formula (1) according to the present invention first synthesizes a polyether compound represented by the following formula (4) by using the cationic ring-opening polymerization of the monomer of formula (3).

[화학식 3](3)

Figure pat00006
Figure pat00006

[화학식 4][Chemical Formula 4]

Figure pat00007
Figure pat00007

상기 식에서, L은 탄소 수 1 내지 20개의 지방족 유도체 또는 방향족 유도체이고; Wherein L is an aliphatic or aromatic derivative having from 1 to 20 carbon atoms;

R1 및 R2는 서로에 관계없이 수소, 탄소 수 1 내지 20개의 지방족 유도체이고, ρ는 0 내지 20 정수의 반복단위이며, X는 F, Cl, Br 및 I이고, 폴리에테르 단위체의 함량(mol%)을 나타내는 m은 m=100이며, A는 수소, 지방족 유도체 또는 CH2X이다. R 1 and R 2 are each independently hydrogen or an aliphatic derivative having 1 to 20 carbon atoms, ρ is a repeating unit of 0 to 20 integers, X is F, Cl, Br And I, and m representing the content (mol%) of the polyether unit is m = 100, and A is hydrogen, an aliphatic derivative or CH 2 X.

하기 화학식 5로 표현되는 폴리에테르 화합물은 유기 용매 중에서 상기 화합물 4로 표현되는 폴리에테르 화합물에 할로겐 치환 반응을 통해서 제조될 수 있다. The polyether compound represented by the following formula (5) can be prepared by subjecting a polyether compound represented by the above-mentioned compound (4) in an organic solvent to a halogen substitution reaction.

본 발명의 실시예 있어서, 상기 할로겐 치환 반응은 CH2X기를 NaSROH와 NaSR의 혼합물과 반응시켜 도입될 수 있으며, R과 ROH는 탄소수 1 내지 20개의 알킬 및 알콕시이다. In an embodiment of the present invention, the halogen substitution reaction can be introduced by reacting a CH 2 X group with a mixture of NaSROH and NaSR, wherein R and ROH are alkyl and alkoxy having 1 to 20 carbon atoms.

용매로는 디메틸아세트아마이드, 디메틸포름아마이드, 디에틸에테르, 디클로로메탄, 테트라하이드로퓨란 또는 그 혼합용액 등이 있다.Examples of the solvent include dimethylacetamide, dimethylformamide, diethyl ether, dichloromethane, tetrahydrofuran or a mixed solution thereof.

이 단계에서의 반응은 -100 내지 100℃의 온도 및 1 내지 5atm의 압력에서 이루어지는 것이 좋다.The reaction at this stage is preferably carried out at a temperature of -100 to 100 DEG C and a pressure of 1 to 5 atm.

[화학식 5][Chemical Formula 5]

Figure pat00008
Figure pat00008

상기 식에서, L은 탄소 수 1 내지 20개의 지방족 유도체 또는 방향족 유도체이고, R1 및 R2는 서로에 관계없이 수소, 탄소 수 1 내지 20개의 지방족 유도체이고, ρ는 0 내지 20 정수의 반복단위이며 Y는 H, -CH2X (X= F, Cl, Br 또는 I), 탄소 수 1 내지 20의 지방족 유도체 또는 -Z 말단에 U를 포함하는 고리 및 지방족 유도체이다. Wherein L is an aliphatic derivative or an aromatic derivative having 1 to 20 carbon atoms, R 1 and R 2 are each independently a hydrogen, an aliphatic derivative having 1 to 20 carbon atoms, and p is a repeating unit of 0 to 20 integers Y is H, -CH 2 X (X═F, Cl, Br or I), an aliphatic derivative having 1 to 20 carbon atoms, or a ring and aliphatic derivative containing at the -Z end.

상기 화학식에서 실질적으로 W는 수산화기(-OH)이고 Z는 링커이다. In the above formula, substantially W is a hydroxyl group (-OH) and Z is a linker.

본 발명에서 실질적으로 화학식 5의 수산화기와 화학식 1에서 U로 표기되는 화학유도체의 축합반응을 통해 화학식 1의 폴리에테르 화합물을 제조한다.In the present invention, the polyether compound of formula (1) is prepared through condensation reaction between the hydroxyl group of formula (5) and the chemical derivative represented by U in formula (1).

본 발명의 실시에 있어서, 상기 화학식(4)의 폴리에테르 화합물은 공지된 방법으로 제조될 수 있으며, 고리형 에테르 화합물을 용매를 사용하지 않거나 디클로로메탄, 클로로포름, 디에틸에테르 등의 용매 중에서 트라이페닐카베니움 헥사플루오로포스페이트 또는 트라이페닐카베니움 헥사클로로안티모니에이트, 알킬 알루미늄 등의 양이온 개시제의 존재하에 양이온 개환 중합 반응하는 단계를 포함한다. In the practice of the present invention, the polyether compound of the above formula (4) can be prepared by a known method, and the cyclic ether compound can be prepared by reacting the cyclic ether compound with triphenylphosphine in a solvent such as dichloromethane, chloroform, A cationic ring-opening polymerization in the presence of a cationic initiator such as carbonylium hexafluorophosphate or triphenylcarbenium hexachloroantimonate, alkyl aluminum, and the like.

상기 축합반응은 브러쉬 말단의 수산화기(-OH)와 화학식 1에서 U로 표기되는 화학유도체의 축합반응이고, 용매로는 디메틸아세트아마이드, 디메틸포름아마이드, 디에틸에테르, 디클로로메탄, 테트라 하이드로퓨란 또는 그 혼합용액 등이 있다.The condensation reaction is a condensation reaction of a hydroxyl group (-OH) at the terminal of the brush with a chemical derivative represented by U in Chemical Formula 1, and examples of the solvent include dimethylacetamide, dimethylformamide, diethyl ether, dichloromethane, tetrahydrofuran, Mixed solution, and the like.

이하, 본 발명의 폴리에테르 화합물의 제조방법을 실시예를 들어 설명하기로 한다.Hereinafter, the method for producing the polyether compound of the present invention will be described by way of examples.

그러나 본 발명은 하기 실시예만 한정하는 것은 아니며, 이 기술분야의 통상의 지식을 가진 자이면 본 발명에 포함된 다양한 결합기나 치환기를 적용하여, 본 발명의 범주에 속하는 다양한 치환기를 가지는 폴리에테르 화합물을 제조하는 것은 충분히 가능한 것이다.However, the present invention is not limited only to the following examples. Any person skilled in the art can apply various binders or substituents included in the present invention to obtain polyether compounds having various substituents belonging to the scope of the present invention It is quite possible to manufacture.

<합성 1><Synthesis 1>

Figure pat00009
Figure pat00009

100㎖의 둥근바닥 플라스크에 40㎖의 에피클로로히드린을 넣고 질소분위기 하에서 5℃로 냉각시켰다. 여기에 0.10g의 개시제(Triphenylcarbenium hexafluorophosphate)를 디클로로메탄에 녹인 용액을 첨가한 후 상온에서 4일간 교반하였다. 40 ml of epichlorohydrin was placed in a 100 ml round bottom flask and cooled to 5 캜 under a nitrogen atmosphere. A solution of 0.10 g of triphenylcarbenium hexafluorophosphate in dichloromethane was added thereto, followed by stirring at room temperature for 4 days.

이 반응물을 소량의 디클로로메탄에 녹인 후 메탄올에 재침전시켜 정제하고, 이를 40℃ 진공 하에서 8시간 건조하여 폴리에피클로로히드린을 제조하였다. The reaction product was dissolved in a small amount of dichloromethane and then purified by reprecipitation in methanol. The reaction product was dried at 40 ° C under vacuum for 8 hours to prepare polyepichlorohydrin.

수율: 65%. 1H-NMR (300 MHz, CDCl3): δ(ppm)=3.89-3.49 (br, 5H, -OCH-, -OCH2-, -CH2Cl); 13C-NMR (75 MHz, CDCl3):δ(ppm)= 79.70, 70.32, 44.31; FTIR(in film):ν(cm-1)= 2960, 2915, 2873, 1427, 1348, 1299, 1263, 1132, 750, 707.Yield: 65%. 1 H-NMR (300 MHz, CDCl 3 ):? (Ppm) = 3.89-3.49 (br, 5H, -OCH-, -OCH 2 -, -CH 2 Cl); 13 C-NMR (75 MHz, CDCl 3 ):? (Ppm) = 79.70, 70.32, 44.31; FTIR (in film):? (Cm -1 ) = 2960, 2915, 2873, 1427, 1348, 1299, 1263, 1132, 750, 707.

<합성 2><Synthesis 2>

Figure pat00010
Figure pat00010

합성1에서 얻은 폴리에피클로로히드린 화합물 558mg을 5㎖의 디메틸아세트아마이드에 녹인 용액에, 나트륨 6-하이드록시헥실싸이올레이트 942mg을 10㎖의 디메틸아세트아마이드에 녹인 용액을 첨가하였다. To a solution of 558 mg of the polyepichlorohydrin compound obtained in Synthesis 1 in 5 ml of dimethylacetamide was added a solution of 942 mg of sodium 6-hydroxyhexylthiolate in 10 ml of dimethylacetamide.

이 혼합액을 50℃에서 2시간 교반한 후 클로로포름으로 추출하고 물로 씻어 용매를 제거한 후, 헥산에 침전시켰다. The mixture was stirred at 50 ° C for 2 hours, extracted with chloroform, washed with water to remove the solvent, and then precipitated in hexane.

이 침전물을 40℃ 진공 하에서 8시간 건조하여 목적 화합물을 얻었다.The precipitate was dried under vacuum at 40 캜 for 8 hours to obtain the target compound.

1H-NMR (300 MHz, CDCl3): δ(ppm)=3.70-3.49 (br, -OCH-, -OCH2-, HOCH2-, -CH2Cl), 2.75-2.52 (m, -CH2SCH2-), 1.57-1.13 (m, -(CH2)4-); 1 H-NMR (300 MHz, CDCl 3): δ (ppm) = 3.70-3.49 (br, -OCH-, -OCH 2 -, HOCH 2 -, -CH 2 Cl), 2.75-2.52 (m, -CH 2 SCH 2 -), 1.57-1.13 (m, - (CH 2 ) 4 -);

<합성 3><Synthesis 3>

Figure pat00011
Figure pat00011

100㎖의 둥근바닥 플라스트에 4-설포벤조산 포타슘염 1.20g, 염화 티오닐 10㎖을 함께 넣고, 디메틸포름아마이드을 한방울 넣어 4시간 동안 질소 분위기하에서 리플럭스 한다. A 100 ml round bottom flask was charged with 1.20 g of 4-sulfobenzoic acid potassium salt and 10 ml of thionyl chloride and refluxed under nitrogen atmosphere for 4 hours with a drop of dimethylformamide.

반응이 끝나면 용매를 냉각하여 침전물이 생기면 필터를 통해 제거하고, 남은 용매를 감압, 가열을 통해 용매를 제거하면 무색결정을 얻을 수 있다. When the reaction is completed, the solvent is cooled to remove the precipitate through the filter, and the remaining solvent is removed by decompression and heating to obtain colorless crystals.

수율: 90%. 1H-NMR (300 MHz, CDCl3): δ(ppm)=8.35 (d, 2H), 8.18 (d, 2H). Yield: 90%. 1 H-NMR (300 MHz, CDCl 3): δ (ppm) = 8.35 (d, 2H), 8.18 (d, 2H).

얻어진 무색결정의 4-(클로로설포닐)벤질 클로라이드 4.01g과 트리에틸아민 10㎖를 디클로로메탄 5㎖에 녹여 0℃로 냉각한 후, 2,2-디메틸-1-프로판올 3㎖와 4-(디메틸아미노)피리딘 0.10g을 넣고 상온에서 4시간 동안 교반한다. To the obtained colorless crystals, 4.01 g of 4- (chlorosulfonyl) benzyl chloride and 10 ml of triethylamine were dissolved in 5 ml of dichloromethane, and the mixture was cooled to 0 캜. Then, 3 ml of 2,2-dimethyl- Dimethylamino) pyridine (0.10 g), and the mixture was stirred at room temperature for 4 hours.

반응이 끝나면 용매를 감압가열을 통해 제거하고 실리카겔 크로마토그래피(1: 6의 에틸아세테이트와 페트롤륨 에테르)를 이용하여 정제한다. At the end of the reaction, the solvent is removed by reduced pressure heating and purified by silica gel chromatography (1: 6 ethyl acetate and petroleum ether).

수율: 80%. 1H-NMR (300 MHz, CDCl3): δ(ppm)=8.24 (d, 2H), 8.00 (d, 2H), 4.1 (s, 2H), 3.79 (s, 2H), 1.15 (s, 9H), 0.90 (s, 9H). Yield: 80%. 1 H-NMR (300 MHz, CDCl 3): δ (ppm) = 8.24 (d, 2H), 8.00 (d, 2H), 4.1 (s, 2H), 3.79 (s, 2H), 1.15 (s, 9H ), 0.90 (s, 9H).

얻어진 네오펜틸 4-((네오펜틸옥시)설포닐)벤조에이트 3.4g을 15㎖의 THF에 용해시키고, 리튬하이드록사이드 모노하이드레이트 0.52g을 15㎖의 증류수에 용해하여 첨가한 후 4 시간 동안 교반한다. 3.4 g of the obtained neopentyl 4 - ((neopentyloxy) sulfonyl) benzoate was dissolved in 15 ml of THF, and 0.52 g of lithium hydroxide monohydrate was added to dissolve in 15 ml of distilled water, followed by stirring for 4 hours do.

반응이 끝나면 5% 하이드로크로릭에시드 용액을 넣어주어서 pH 2의 산성용액으로 만든다.At the end of the reaction, add 5% hydrochloric acid solution to make acidic solution of pH 2.

감압, 가열을 통하여 THF를 모두 제거하고, 디클로로메탄 100㎖를 첨가하고 증류수로 씻어준다. THF is removed by reduced pressure and heating, 100 ml of dichloromethane is added, and the mixture is washed with distilled water.

추출한 유기용매는 마그네슘설파이트를 이용하여 수분을 제거하고, 감압가열을 통해서 용매를 모두 제거하고 건조하면 4-((네오펜틸옥시)설포닐)벤조산을 얻을 수 있다. The extracted organic solvent is removed by using magnesium sulfite, and the solvent is removed by heating under reduced pressure and then dried to obtain 4 - ((neopentyloxy) sulfonyl) benzoic acid.

수율: 80%. 1H-NMR (300 MHz, CDCl3): δ(ppm)=8.24 (d, 2H), 8.00 (d, 2H), 3.79 (s, 2H), 0.90 (s, 9H).Yield: 80%. 1 H-NMR (300 MHz, CDCl 3): δ (ppm) = 8.24 (d, 2H), 8.00 (d, 2H), 3.79 (s, 2H), 0.90 (s, 9H).

<합성 4><Synthesis 4>

Figure pat00012
Figure pat00012

10㎖의 둥근 바닥 플라스크에 3,5-디메틸피라졸 5.77g과 디부틸틴 라우레이트 0.02g을 120㎖의 톨루엔에 함께 녹이고, 헥사메틸렌 디이소시아네이트 9.64㎖을 25㎖의 톨루엔에 녹인 용액을 천천히 넣어준다. 5.77 g of 3,5-dimethylpyrazole and 0.02 g of dibutyltin laurate were dissolved in 120 mL of toluene, and 9.64 mL of hexamethylene diisocyanate dissolved in 25 mL of toluene was slowly added to a 10 mL round bottom flask give.

3시간 동안 리플럭스 후에, 용액을 냉각시켜 0℃에서 12시간 보관한다. After reflux for 3 hours, cool the solution and store at 0 ° C for 12 hours.

용액에 흰색 침전물이 생기면 감압필터를 통해 모아 다시 클로로포름용액에 녹여서 남은 침전물을 다시 필터를 통해 제거 후, 남은 유기용매를 감압가열로 제거하여 진공 건조한다. When a white precipitate is formed in the solution, it is collected through a decompression filter and dissolved again in chloroform solution. The remaining precipitate is again removed through a filter, and the remaining organic solvent is removed by reduced pressure heating and vacuum drying is performed.

수율: 50%. 1H-NMR (300 MHz, CDCl3):δ(ppm)= 7.24 (s, 1H), 5.89 (s, 1H), 3.34 (m, 2H), 3.19 (m, 2H), 2.54 (s, 3H), 2.19 (s, 3H), 1.8-1.25 (m, 8H).Yield: 50%. 1 H-NMR (300 MHz, CDCl 3): δ (ppm) = 7.24 (s, 1H), 5.89 (s, 1H), 3.34 (m, 2H), 3.19 (m, 2H), 2.54 (s, 3H ), 2.19 (s, 3H), 1.8-1.25 (m, 8H).

<합성 5><Synthesis 5>

Figure pat00013
Figure pat00013

합성 2에서 얻은 고분자 화합물 270mg과 N-아세틸글리신 35mg, 시나믹에이시드 30mg, 합성 3에서 얻은 화합물 27mg, N-(3-디메틸아미노프로필)-N'-에틸카보디이미드 하이드로클로라이드 172mg, 4-(디메틸아미노)피리딘 61mg을 10㎖의 디메틸포름아마이드에 녹인 후, 50℃에서 24시간 동안 가열하면서 교반한다.27 mg of the compound obtained in Synthesis 3, 172 mg of N- (3-dimethylaminopropyl) -N'-ethylcarbodiimide hydrochloride, 28 mg of N- (Dimethylamino) pyridine were dissolved in 10 ml of dimethylformamide, and the mixture was stirred while heating at 50 占 폚 for 24 hours.

반응이 완료되면 상온으로 식힌 후 200㎖ 메탄올/증류수(메탄올= 20Vol%: 증류수= 80Vol%)에 침전시킨 후 침전용매를 제거하고, 남은 고상 물질을 디클로로메탄에 녹여서 마그네슘설파이트로 수분을 제거한다. After the reaction was completed, the reaction mixture was cooled to room temperature and then precipitated in 200 ml of methanol / distilled water (methanol = 20 vol%: distilled water = 80 vol%). The precipitating solvent was removed, and the remaining solid matter was dissolved in dichloromethane to remove moisture with magnesium sulfite .

수분을 제거한 용매를 감압, 가열을 통하여 제거하고 진공 건조시킨다.The solvent from which the moisture has been removed is removed through reduced pressure and heating, and vacuum drying is performed.

1H-NMR (300 MHz, CDCl3) 8.20 (d, Ar-H), 8.01 (d, Ar-H), 7.65 (d, -CH=), 7.51 (m, Ar-H), 7.40 (m, Ar-H), 6.41 (d, -CH=), 4.40 (t, -CH2OCO-), 4.20 (m, -CH2OCO-), 4.08 (m, -CH2OCO-), 3.90-3.40 (br, -OCH-, -OCH2-, HOCH2-, -CH2Cl-, -NHCH2COO-), 2.81-2.54 (m, -CH2SCH2-), 2.10 (s, -NHCOCH3), 1.90-1.2 (m, -(CH2)4-), 0.90 (s, -CH3); 1 H-NMR (300 MHz, CDCl 3) 8.20 (d, Ar-H), 8.01 (d, Ar-H), 7.65 (d, -CH =), 7.51 (m, Ar-H), 7.40 (m , 4.40 (t, -CH 2 OCO-), 4.20 (m, -CH 2 OCO-), 4.08 (m, -CH 2 OCO-), 3.90 3.40 (br, -OCH-, -OCH 2 -, HOCH 2 -, -CH 2 Cl-, -NHCH 2 COO-), 2.81-2.54 (m, -CH 2 SCH 2 -), 2.10 (s, -NHCOCH 3 ), 1.90-1.2 (m, - (CH 2 ) 4 -), 0.90 (s, -CH 3 );

<합성 6><Synthesis 6>

Figure pat00014
Figure pat00014

합성 5에서 얻은 고분자 화합물 363mg과 3,5-디메틸피라졸 블록이소시아네이트 52mg, 트리에틸아민 1㎖를 10㎖의 디메틸포름아마이드에 녹인 후 상온에서 24 시간 동안 교반한다. 363 mg of the polymer compound obtained in Synthesis 5, 52 mg of 3,5-dimethylpyrazole block isocyanate and 1 ml of triethylamine were dissolved in 10 ml of dimethylformamide, followed by stirring at room temperature for 24 hours.

반응이 완료되면 메탄올/증류수(메탄올= 20 Vol% : 증류수= 80 Vol%)에 침전시킨 후 침전 용매를 제거하고, 남은 고상 물질을 디클로로메탄에 녹여서 마그네슘설파이트로 수분을 제거한다. After the reaction is completed, precipitate in methanol / distilled water (methanol = 20 vol%: distilled water = 80 vol%), remove the precipitating solvent, dissolve the remaining solid matter in dichloromethane, and remove moisture with magnesium sulfite.

수분을 제거한 용매를 감압, 가열을 통하여 제거하고 진공, 건조시킨다.The solvent from which moisture has been removed is removed through reduced pressure and heating, and vacuum dried.

1H-NMR (300 MHz, CDCl3) 8.20 (d, Ar-H), 8.01 (d, Ar-H), 7.65 (d, -CH=), 7.51 (m, Ar-H), 7.40 (m, Ar-H), 6.41 (d, -CH=), 5.90 (s, -CH=C(CH3)-), 4.40 (t, -CH2OCO-), 4.20 (m, -CH2OCO-), 4.08 (m, -CH2OCO-), 3.90-3.40 (br, -OCH-, -OCH2-, HOCH2-, -CH2Cl-, -NHCH2COO-), 3.40 (m, -CH2NHCO-), 3.20 (m, -CH2NHCO-), 2.81-2.45 (m, -CH2SCH2-), 2.54 (s, -CH3), 2.20 (s, -CH3), 2.10 (s, -NHCOCH3), 1.90-1.2 (m, -(CH2)4-), 0.90 (s, -CH3); 1 H-NMR (300 MHz, CDCl 3) 8.20 (d, Ar-H), 8.01 (d, Ar-H), 7.65 (d, -CH =), 7.51 (m, Ar-H), 7.40 (m , Ar-H), 6.41 ( d, -CH =), 5.90 (s, -CH = C (CH 3) -), 4.40 (t, -CH 2 OCO-), 4.20 (m, -CH 2 OCO- ), 4.08 (m, -CH 2 OCO-), 3.90-3.40 (br, -OCH-, -OCH 2 -, HOCH 2 -, -CH 2 Cl-, -NHCH 2 COO-), 3.40 CH 2 NHCO-), 3.20 (m , -CH 2 NHCO-), 2.81-2.45 (m, -CH 2 SCH 2 -), 2.54 (s, -CH 3), 2.20 (s, -CH 3), 2.10 (s, -NHCOCH 3), 1.90-1.2 (m, - (CH 2) 4 -), 0.90 (s, -CH 3);

<고분자 박막의 형성 및 평가>&Lt; Formation and Evaluation of Polymer Thin Films >

위에서 제조한 최종 폴리에테르 화합물(l=10, o=10, p=10, q=10, r=10, n=50)을 클로로포름 용매(1 내지 7wt%)에 질량 퍼센트를 달리하여 용해 시킨 후, 0.2 마이크로 필터의 실린지 필터로 걸러낸 수지 용액을 글라스 슬라이드 위에 스핀 코팅, 스프레이 코팅, 정전기 코팅, 딥코팅, 블레이트 코팅, 잉크젯 코팅 및 롤 코팅 등의 방법으로 코팅하고, 진공 하에서 50℃로 12시간 동안 열처리하여 글라스 슬라이드 위에 30㎛ 두께의 고분자 박막을 형성시켰다.The final polyether compound (l = 10, o = 10, p = 10, q = 10, r = 10, n = 50) prepared above was dissolved in chloroform solvent (1-7 wt% , 0.2 micro filter was coated with a resin solution filtered with a syringe filter by a method such as spin coating, spray coating, electrostatic coating, dip coating, blit coating, ink jet coating and roll coating on a glass slide, Treated for 12 hours to form a polymer thin film having a thickness of 30 탆 on a glass slide.

상기에서 제조한 고분자 박막의 자가치유 특성을 아래와 같이 평가하였다.The self-healing properties of the polymer thin films prepared above were evaluated as follows.

먼저, 자가치유 특성의 평가를 위해 열처리와 UV조사의 두 가지 조건을 주었다. First, to evaluate the self-healing properties, two conditions were given: heat treatment and UV irradiation.

브러쉬 고분자 박막 표면의 미세손상의 회복 정도를 측정하기 위해서 면도칼을 이용하여 표면에 미세 손상을 가한 후, 앞에서 언급한 열처리 과정에서는 질소 분위기에서 100℃로 1-3 시간 동안 시간을 조절하여 열처리를 해주었으며, UV 조사과정에서는 UV 노광기를 사용하여 UV 조사시간을 5분 내지 1시간 범위로 조절하여 UV 조사를 해주었다(도 1 참조). In order to measure the degree of recovery of micro-damage on the surface of the polymer polymer thin film, micro-damage was applied to the surface using a razor, and the heat treatment was performed by controlling the time at 100 ° C. for 1-3 hours in the nitrogen atmosphere In the UV irradiation process, the UV irradiation time was adjusted to a range of 5 minutes to 1 hour using a UV exposure apparatus, and UV irradiation was performed (see FIG. 1).

이후, 표면단차측정기를 이용해서 고분자 박막 표면의 두께 변화를 측정하였으며(도 3 참조), 광학 현미경 카메라를 이용하여 이미지를 얻어 열처리 및 UV 조사 전후 차이를 비교하여 자가치유 특성을 평가하였다(도 2 참조).Then, the thickness variation of the surface of the polymer thin film was measured using a surface step measuring instrument (see FIG. 3), images were obtained using an optical microscope camera, and self-healing characteristics were evaluated by comparing the difference between before and after the heat treatment and UV irradiation Reference).

이상의 결과에 나타난 바와 같이 본 발명의 폴리에테르 화합물은 도막에 대한 자가치유 기능이 우수한 것임을 확인할 수 있었다.As shown in the above results, it was confirmed that the polyether compound of the present invention has an excellent self-healing function against the coating film.

상기 도면과 발명의 상세한 설명은 단지 본 발명의 예시적인 것으로서, 이는 단지 본 발명을 설명하기 위한 목적에서 사용된 것이지 의미 한정이나 특허청구범위에 기재된 본 발명의 범위를 제한하기 위하여 사용된 것은 아니다. The drawings and the detailed description of the invention are merely illustrative of the invention and are used merely for the purpose of describing the invention and not for limiting the scope of the invention as set forth in the claims or the claims.

그러므로 본 기술 분야의 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 타 실시예가 가능하다는 점을 이해할 것이다. Therefore, those skilled in the art will appreciate that various modifications and equivalent embodiments are possible without departing from the scope of the present invention.

따라서 본 발명의 진정한 기술적 보호 범위는 첨부된 특허청구범위의 기술적 사상에 의해 정해져야 할 것이다.Accordingly, the true scope of the present invention should be determined by the technical idea of the appended claims.

Claims (5)

하기 화학식 1로 표시되는 자가치유 기능 폴리에테르 화합물:
[화학식 1]
Figure pat00015

상기 식에서, L은 탄소 수 1 내지 20개의 지방족 유도체 또는 방향족 유도체이고;
R1 및 R2는 서로에 관계없이 수소, 탄소 수 1 내지 20개의 지방족 유도체이고, ρ는 0 내지 20 정수의 반복단위이며;
m 및 n은 폴리에테르 단위체의 함량(mol%)을 나타낸 것으로, 0≤m<100이고 0≤n<100이며, m + n = 100이고;
Y는 H, -CH2X (X= F, Cl, Br 또는 I), 탄소 수 1 내지 20개의 지방족 유도체 또는 -Z 말단에 U를 포함하는 고리 및 지방족 유도체이고;
Z는 폴리에테르 주쇄와 자가치유 기능성 분자를 연결시켜주는 링커로, -CH2SRO-, -CH2SROCO-, -CH2SRCOO-, -CH2SRO-, -CH2SRNHCO-, -CH2SROCO(CH2)2OCO-, -CH2SRCO-, -CH2SO2RO-, -CH2SO2ROCO-, -CH2SO2RCOO-, -CH2SO2RNHCO-, -CH2SO2ROCO(CH2)2OCO-, -CH2SO2RCO-, -OCORO-, -OCOROCO-, -OCORCOO-, -OCORNHCO-, -OCOROCO(CH2)2OCO-, -OCORCO-, -COORO-, -COOROCO-, -COORCOO-, -COORNHCO-, -COOROCO(CH2)2OCO-, -COORCO-, -ORO-, -OROCO-, -ORCOO-, -ORNHCO-, -OROCO(CH2)2OCO-, -ORCO-, -NHRO-, -NHROCO-, -NHRCOO-, -NHRNHCO-, -NHROCO(CH2)2OCO-, -NHRCO-, -CH2RO-, -CH2ROCO-, -CH2RCOO-, -CH2RNHCO-, -CH2ROCO(CH2)2OCO-, -OC6H4RO-, -OC6H4ROCO-, -OC6H4RCOO-, -OC6H4RNHCO-, -OC6H4ROCO(CH2)2OCO-, -OC6H4RCO-, -OC6H4COOROCO-, -OC6H4COORCOO-, -OC6H4COORO-, -OC6H4COORNHCO-, -OC6H4COOROCO(CH2)2OCO-, -OC6H4COORCO- 또는 -OC6H4CONHROCO-, -OC6H4CONHRCOO-, -OC6H4CONHRO-, -OC6H4CONHRNHCO-, -OC6H4CONHROCO(CH2)2OCO-, -OC6H4CONHRCO-로 이루어진 군으로부터 선택되는 지방족 또는 방향족 유도체이며, 여기에서 R은 수소, 탄소 수 1 내지 20의 지방족 유도체이고;
U는 수산화기 또는 하기에 표기한 화학유도체로 이루어진 군에서 2 내지 10개의 화학유도체로 선택되고, 바람직하게는 2 내지 5개의 화학유도체로 선택된다. 여기에서 R은 수소, 탄소 수 1 내지 20개의 지방족 유도체 또는 방향족 유도체이다.
Figure pat00016

Figure pat00017
A self-healing functional polyether compound represented by the following formula (1)
[Chemical Formula 1]
Figure pat00015

Wherein L is an aliphatic or aromatic derivative having from 1 to 20 carbon atoms;
R 1 and R 2 are each independently hydrogen or an aliphatic derivative having 1 to 20 carbon atoms, and p is a repeating unit of 0 to 20 integers;
m and n represent the content (mol%) of the polyether unit, 0? m <100, 0? n <100, m + n = 100;
Y is H, -CH 2 X (X = F, Cl, Br or I), a ring carbon and an aliphatic derivative comprising a U in 1 to 20 aliphatic derivatives or -Z-terminal;
Z is a linker linking the polyether backbone and the self-healing functional molecule and is selected from the group consisting of -CH 2 SRO-, -CH 2 SROCO-, -CH 2 SRCOO-, -CH 2 SRO-, -CH 2 SRNHCO-, -CH 2 SROCO (CH 2) 2 OCO-, -CH 2 SRCO-, -CH 2 SO 2 RO-, -CH 2 SO 2 ROCO-, -CH 2 SO 2 RCOO-, -CH 2 SO 2 RNHCO-, -CH 2 SO 2 ROCO (CH 2 ) 2 OCO-, -CH 2 SO 2 RCO-, -OCORO-, -OCOROCO-, -OCORCOO-, -OCORNHCO-, -OCOROCO (CH 2 ) 2 OCO-, COORO-, -COOROCO-, -COORCOO-, -COORNHCO-, -COOROCO (CH 2) 2 OCO-, -COORCO-, -ORO-, -OROCO-, -ORCOO-, -ORNHCO-, -OROCO (CH 2 ) 2 OCO-, -ORCO-, -NHRO-, -NHRCO-, -NHRCO-, -NHRNHCO-, -NHROCO (CH 2 ) 2 OCO-, -NHRCO-, -CH 2 RO-, -CH 2 ROCO- , -CH 2 RCOO-, -CH 2 RNHCO-, -CH 2 ROCO (CH 2 ) 2 OCO-, -OC 6 H 4 RO-, -OC 6 H 4 ROCO-, -OC 6 H 4 RCOO-, OC 6 H 4 RNHCO-, -OC 6 H 4 ROCO (CH 2 ) 2 OCO-, -OC 6 H 4 RCO-, -OC 6 H 4 COOROCO-, -OC 6 H 4 COORCOO-, -OC 6 H 4 -OC 6 H 4 COOR NHCO-, -OC 6 H 4 COOROCO (CH 2 ) 2 OCO-, -OC 6 H 4 COORCO- or -OC 6 H 4 CONHROCO-, -OC 6 H 4 CONHRCOO-, OC 6 H 4 CONHRO-, -O C 6 H 4 CONHRNHCO-, -OC 6 H 4 CONHROCO (CH 2 ) 2 OCO-, and -OC 6 H 4 CONHRCO-, wherein R is selected from the group consisting of hydrogen, 20 &lt; / RTI &gt; aliphatic derivative;
U is selected from 2 to 10 chemical derivatives, preferably 2 to 5 chemical derivatives, in the group consisting of hydroxyl groups or chemical derivatives indicated below. Wherein R is hydrogen, an aliphatic or aromatic derivative of 1 to 20 carbon atoms.
Figure pat00016

Figure pat00017
제1항에 있어서,
상기 자가치유 기능 폴리에테르 화합물은 하기 화학식 2의 폴리[옥시((N-아세틸글라이시닐옥시)헥실티오메틸)에틸렌-랜-옥시((시나모일옥시)헥실티오메틸)에틸렌-랜-옥시((4-네오펜티옥시설포닐벤조익)헥실티오메틸)에틸렌-랜-옥시((6-(3,5-디메틸-1H-피라졸-1-카르복사미도헥실카바메이트))헥실티오메틸)에틸렌-랜-옥시(6-하이드록시헥실티오메틸)에틸렌-랜-옥시(클로로메틸)에틸렌]인 자가치유 기능 폴리에테르 화합물.
[화학식 2]
Figure pat00018
The method according to claim 1,
Wherein the self-healing functional polyether compound is selected from the group consisting of poly [oxy ((N-acetylglycinyloxy) hexylthiomethyl) ethylene-ranoxy (cinnamoyloxy) hexylthiomethyl) ethylene- ((6- (3,5-dimethyl-1H-pyrazole-1-carboximidohexylcarbamate)) hexylthiomethyl) ethylene- (6-hydroxyhexylthiomethyl) ethylene-l-oxy (chloromethyl) ethylene] ethylene-co-healing function polyether compound.
(2)
Figure pat00018
제1항에 있어서,
상기 자가치유 기능 폴리에테르 화합물의 중량평균 분자량은 5,000 내지 5,000,000인 자가치유 기능 폴리에테르 화합물.
The method according to claim 1,
Wherein the self-healing function polyether compound has a weight average molecular weight of 5,000 to 5,000,000.
하기 화학식 3으로 표현되는 고리형태의 단량체를 양이온 개환 중합 반응을 통하여 하기 화학식 4의 폴리에테르 화합물을 제조하는 제1공정;
화학식 4의 폴리에테르 화합물을 유기 용매 중에서 할로겐 치환 반응을 통하여 하기 화학식 5의 폴리에테르 화합물을 제조하는 제2공정;
화학식 5의 폴리에테르 화합물에 자가치유 기능성 분자를 도입하고 축합반응을 통해 형성된 제3공정으로 이루어진 것을 특징으로 하는 화학식 1의 자가치유 기능 폴리에테르 화합물의 제조방법.
[화학식 1]
Figure pat00019

[화학식 3]
Figure pat00020

[화학식 4]
Figure pat00021

[화학식 5]
Figure pat00022

(여기서, R1 및 R2, L, m, n, P, U, Y, Z는 청구항 1의 정의된 바와 같고, A는 수소, 지방족 유도체 또는 CH2X이고, W는 수산화기 이다.)
A first step of preparing a polyether compound represented by the following formula (4) through a cationic ring-opening polymerization reaction of a cyclic monomer represented by the following formula (3);
A second step of preparing a polyether compound represented by the following formula (5) by halogen substitution reaction of the polyether compound represented by the formula (4) in an organic solvent;
A process for producing a self-healing functional polyether compound represented by the formula (1), characterized by comprising a third step of introducing an auto-healing functional molecule into the polyether compound of formula (5) and forming through condensation reaction.
[Chemical Formula 1]
Figure pat00019

(3)
Figure pat00020

[Chemical Formula 4]
Figure pat00021

[Chemical Formula 5]
Figure pat00022

Wherein A is hydrogen, an aliphatic derivative or CH 2 X and W is a hydroxyl group. 2. A process according to claim 1, wherein R 1 and R 2 , L, m, n, P, U, Y and Z are as defined in claim 1;
상기 화학식 1의 자가치유 폴리에테르 화합물로 구성되는 것을 특징으로 하는 자가 치유 기능 고분자 박막.Wherein said self-healing polyether compound is represented by Formula (1).
KR1020160067532A 2016-05-31 2016-05-31 Self-healing polyethers and process for the preparation thereof KR101836967B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020160067532A KR101836967B1 (en) 2016-05-31 2016-05-31 Self-healing polyethers and process for the preparation thereof
PCT/KR2017/005634 WO2017209486A1 (en) 2016-05-31 2017-05-30 Self-healing polyether compound and preparation method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160067532A KR101836967B1 (en) 2016-05-31 2016-05-31 Self-healing polyethers and process for the preparation thereof

Publications (2)

Publication Number Publication Date
KR20170136123A true KR20170136123A (en) 2017-12-11
KR101836967B1 KR101836967B1 (en) 2018-03-12

Family

ID=60478628

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160067532A KR101836967B1 (en) 2016-05-31 2016-05-31 Self-healing polyethers and process for the preparation thereof

Country Status (2)

Country Link
KR (1) KR101836967B1 (en)
WO (1) WO2017209486A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101947594B1 (en) * 2017-04-13 2019-02-14 주식회사 쎄코 Self-healing polyvinyl and method for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548674B1 (en) * 1983-07-04 1986-05-02 Saint Gobain Vitrage PROCESS FOR TREATING THE SURFACE OF A TRANSPARENT LAYER HAVING ANTILACERATION AND SELF-HEALING PROPERTIES
WO1996010595A1 (en) * 1994-10-04 1996-04-11 Minnesota Mining And Manufacturing Company Reactive two-part polyurethane compositions and optionally self-healable and scratch-resistant coatings prepared therefrom
KR101053247B1 (en) * 2008-12-30 2011-08-01 포항공과대학교 산학협력단 Method for preparing functional brush polymer having mercury ion sensing molecules at the end and sensing mercury ions using surface plasmon spectroscopy
KR101218759B1 (en) * 2010-12-22 2013-01-08 포항공과대학교 산학협력단 Carbohydrates and their mimics containing self-assembled brush polyether-based polymers for bio-applications, preparation thereof, and products comprising the polymers
KR101260328B1 (en) * 2011-03-28 2013-05-03 포항공과대학교 산학협력단 Dialkyl aminoalkyl sulfone and their mimics containing self-assembled brush polyether-based polymers for bio-applications, preparation thereof products comprising the polymer

Also Published As

Publication number Publication date
KR101836967B1 (en) 2018-03-12
WO2017209486A1 (en) 2017-12-07

Similar Documents

Publication Publication Date Title
He et al. Synthesis, characterization, and application of a bifunctional coupler containing a five-and a six-membered ring carbonate
JP5280856B2 (en) Cationic hydrophilic siloxanyl monomer
EP3486238B1 (en) Polyfunctional oxetane derivatives for preparing cationic photocurable compositions
EP2994493B1 (en) Sugar containing, amphiphilic copolymers
EP0716044B1 (en) Fullerene polymers
JP6545159B2 (en) 2-oxo-1,3-dioxolane-4-acyl halides, their preparation and use
US7151152B2 (en) Crosslinked body and method of producing the same and method of recycling the same
EP3663328A1 (en) Hydrophilic polyamide or polyimide
US10577456B2 (en) Halogenated cyclic diesters, related polymers, and methods for their preparation and use
KR101947594B1 (en) Self-healing polyvinyl and method for preparing the same
KR101836967B1 (en) Self-healing polyethers and process for the preparation thereof
CN113501963B (en) 3-azidomethyl-3-methyloxetane-tetrahydrofuran energetic copolyether with alternating multi-block structure and synthesis method thereof
EP2780320B1 (en) New process of preparation of polyols and polyamines, and products as obtained
JP4225014B2 (en) Polythiourethane and process for producing the same
US5767284A (en) Process for producing a polyoxyalkylene derivative substituted with succinimidyl group
RU2387634C1 (en) Oligo oxypropylene acrylates for primary layer of polymer coating of optical guides and synthesis method thereof
KR101598545B1 (en) Polyamide-based photoreactive polymer and preparation method thereof
KR101053247B1 (en) Method for preparing functional brush polymer having mercury ion sensing molecules at the end and sensing mercury ions using surface plasmon spectroscopy
JP6992976B2 (en) Method for Producing Trimethylene Carbonate Derivative
KR101828825B1 (en) Cell-membrane mimicking brush polymers and a method for preparaing thereof
WO2017170705A1 (en) Biodegradable hydrogel having cyclic benzylidene acetal structure
SU804656A1 (en) Polyphenethylsilysesquioxans as film-producing agents of increesed elastocity and
CN108558705B (en) Aryl carbamate monomer containing phenolic hydroxyl amino acid, preparation method and application
JP5003324B2 (en) Compound, production method thereof and polymer thereof
KR100730237B1 (en) Preparation method of polymers containing quadruple hydrogen bonding

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant